Joseph Vittiglio
CIK 1551776 · Chief Business & Legal Officer · last filed 2026-03-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
AMAG price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
455 GRAND UNION BLVD
SOMERVILLE, MA 02145
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PEPG | Chief Business & Legal Officer | 65,717 | $2.45 | $161.0K | $0 | 2 | 2026-03-02 |
| bluebird bio, Inc. (BLUE) Delisted | Chief Business & Legal Officer | 3,125 | $4.97 | $15.5K | -$6.5K | 6 | 2025-06-03 |
| Finch Therapeutics Group, Inc. (FNCH) Delisted | Chief Business & Legal Officer | 1,045 | $7.30 | $7.6K | -$5.1K | 4 | 2022-10-25 |
| AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Chief Business Officer, GC | 0 | — | — | -$56.9K | 17 | 2020-11-17 |
| AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | SVP, General Counsel | 2,092 | $15.00 | $31.4K | -$15.5K | 5 | 2015-01-08 |
Recent Filings · Page 3 of 4
36 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-02-27 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Grant (A) | +32,000 | $0 | EDGAR |
| 2019-02-26 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Tax (F) | −869 | -$13.5K | EDGAR |
| 2018-08-27 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Tax (F) | −1,473 | -$36.2K | EDGAR |
| 2018-03-06 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Mixed | +19,350 | -$54.3K | EDGAR |
| 2017-08-30 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Sell (S) | −1,250 | -$20.9K | EDGAR |
| 2017-08-28 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Tax (F) | −1,633 | -$28.6K | EDGAR |
| 2017-05-10 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Tax (F) | −980 | -$18.2K | EDGAR |
| 2017-02-27 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Grant (A) | +15,000 | $0 | EDGAR |
| 2016-08-25 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Tax (F) | −1,633 | -$40.6K | EDGAR |
| 2016-03-02 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Grant (A) | +9,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.